Prabhudas Lilladher's research report on Marico
MRCO delivered 22% revenue growth along with ~9% volume growth led by prices hikes taken in Parachute, robust growth in Foods and Premium Personal Care along with sustained recovery in VAHO. IBD continues to grow strong with ~19% CCG and is also focusing on improving mix by reducing reliance on Bangladesh and aspirations for double-digit CCG over medium term. Innovation funnel remains strong with portfolio diversification and scale up in Foods, D2C portfolio & B2C acquisitions. Foods are poised for 25%+ CAGR, supported by scaling existing franchises and continued innovation. Exit ARR for FY27 is now projected at ~2.5x FY24 ARR. Beardo has double-digit EBITDA margins whereas Plix has broken even. MRCO plans to adopt the same strategy for scaling Digital-first franchises and targets double-digit margins by FY27.
Outlook
Although we expect near term volatility, strong sales momentum in B2C, Foods and revival of growth in VAHO are positive. We estimate a CAGR of 12% in EPS over FY25-27. We value MRCO at 47x June27 EPS and assign a target price of Rs 743(Rs718 earlier). Retain Accumulate.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
